1116 related articles for article (PubMed ID: 18991188)
1. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities.
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S; Ciołkiewicz M
Arch Immunol Ther Exp (Warsz); 2007; 55(3):179-85. PubMed ID: 17557150
[TBL] [Abstract][Full Text] [Related]
4. Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients.
Ciołkiewicz M; Kuryliszyn-Moskal A; Klimiuk PA
Clin Rheumatol; 2010 Feb; 29(2):175-80. PubMed ID: 19907914
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
6. Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations.
Moneib HA; Salem SA; Aly DG; Khedr HT; Wafaey HA; Hassan HE
J Dermatol; 2012 Jan; 39(1):52-7. PubMed ID: 21950586
[TBL] [Abstract][Full Text] [Related]
7. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
[TBL] [Abstract][Full Text] [Related]
8. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
11. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile.
Riccieri V; Spadaro A; Ceccarelli F; Scrivo R; Germano V; Valesini G
Lupus; 2005; 14(7):521-5. PubMed ID: 16130507
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic activity in sera of patients with systemic lupus erythematosus.
Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
[TBL] [Abstract][Full Text] [Related]
13. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
Frijns R; Fijnheer R; Schiel A; Donders R; Sixma J; Derksen R
J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951
[TBL] [Abstract][Full Text] [Related]
14. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
Wais T; Fierz W; Stoll T; Villiger PM
J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
16. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus.
Constans J; Dupuy R; Blann AD; Resplandy F; Seigneur M; Renard M; Longy-Boursier M; Schaeverbeke T; Guérin V; Boisseau MR; Conri C
J Rheumatol; 2003 Sep; 30(9):1963-6. PubMed ID: 12966599
[TBL] [Abstract][Full Text] [Related]
17. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
[TBL] [Abstract][Full Text] [Related]
18. Association of Nail Dystrophy With Accrued Damage and Capillaroscopic Abnormalities in Systemic Lupus Erythematosus.
Higuera V; Amezcua-Guerra LM; Montoya H; Massó F; Patlán M; Paez A; Varela E; Rodríguez-Galicia V; Silveira LH
J Clin Rheumatol; 2016 Jan; 22(1):13-8. PubMed ID: 26693621
[TBL] [Abstract][Full Text] [Related]
19. Nailfold capillaroscopic changes in patients with systemic lupus erythematosus: correlations with disease activity, skin manifestation and nephritis.
Shenavandeh S; Habibi S
Lupus; 2017 Aug; 26(9):959-966. PubMed ID: 28056626
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities.
Riccieri V; Rinaldi T; Spadaro A; Scrivo R; Ceccarelli F; Franco MD; Taccari E; Valesini G
Clin Rheumatol; 2003 May; 22(2):102-6. PubMed ID: 12740673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
